Hypertensive patient’s journey in Poland

Poor adherence to medical treatment is a significant public health issue, with nearly 50% of patients failing to comply with prescribed medications. In hypertension (HTN), self-reported non-adherence may also affect over half of patients, leading to severe consequences, including increased morbidity and mortality. Given the multifaceted nature of adherence barriers, a structured approach is needed. This study aims to analyse the Patient Journey in hypertension management within Poland, highlighting experiences, key challenges and faced emotions for both patients and physicians, as well as opportunities for improving adherence. A qualitative study was conducted using in-depth individual interviews with 12 hypertensive patients from various regions of Poland and 14 medical doctors (primary care physicians and cardiologists) from public and private healthcare facilities. The study examined patient experiences, physician perspectives, and systemic factors that influence adherence. The patient journey in HTN management consists of six stages: pre-diagnosis, diagnosis, therapy implementation, first-year therapy, cardiovascular event, and long-term therapy. These stages differ in the barriers and emotions experienced by the patient and the clinician, allowing the focus to be directed on selected aspects that most effectively support the diagnostic and therapeutic process. Key identified patients’ barriers include lack of symptom awareness, insufficient informational support, emotional reactions to diagnosis, polypharmacy, financial constraints, and limited healthcare provider engagement. Physicians face challenges related to time constraints, limited systemic support, and patient reluctance to cooperate. Understanding the patient journey provides a structured approach to identifying modifiable adherence barriers. Addressing these factors through patient education, tailored support strategies, and improved physician-patient communication can enhance long-term adherence.